Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 745-750

  Giuffrè, Giuseppe ^a   Simone, Angela ^a   Todaro, Paolo ^a   Le Donne, Maria ^a   Caruso, Carmela ^a   Pizzo, Alfonsa ^a   Granese, Domenico ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Genotypes; HPV infection; Italy; Prevalence; Sicily

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; DNA DETERMINATION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; ITALY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; OUTPATIENTS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; VAGINAL SMEARS;

EID: 77349120018     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000693     Document Type: Article

References (39)

1. zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698, 2000.
2. De Villiers EM, Fauquet C, Broker TR, Bernard HU and zur Hausen H: Classification of papillomaviruses. Virology 324: 17-27, 2004.
3. Scheurer ME, Tortolero-Luna G and Adler-Storthz K: Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 15: 727-746, 2005.
4. Trottier H and Franco EL: The epidemiology of genital human papillomavirus infection. Vaccine 24S1: S1/4-S1/15, 2006.
5. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L and Buonaguro FM, Italian HPV Working Group: Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the italian population. J Med Virol 78: 1663-1672, 2006.
6. Van Ranst M, Kaplan JB and Burk RD: Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 73: 2653-2660, 2006.
7. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellague X, Shah KV, Snijders PJF and Meijer CJLM for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003.
8. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
9. Dokianakis DN, Sourvinos G, Sakkas S, Athanasiadou E and Spandidos DA: Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep 5: 1195-1198, 1998.
10. Dokianakis DN, Papaefthimiou M, Tsiveleka A and Spandidos DA: High prevalence of HPV 18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears. Oncol Rep 6: 1327-1331, 1999.
11. Arbyn M, Buntinx F, van Ranst M, Paraskevaidis E, Martin-Hirsch P and Dillner J: Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96: 280-293, 2004.
12. Solomon D, Schiffman M and Tarone RI: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93: 293-299, 2001.
13. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F and Franco EL for the Canadian Cervical Cancer Screening Trial Study Group: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579-1588, 2007.
14. Naucler P, Ryd W, Tönberg S, Strand A, Wadell G, Elfgren K, Råberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E and Dillner J: Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357: 1589-1597, 2007.
15. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de SanjoséS, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ and Franceschi S for IARC HPV Prevalence Surveys Study Group: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-998, 2005.
16. Baseman JG and Koutsky LA: The epidemiology of human papillomavirus infections. J Clin Virol 32: S16-S24, 2005.
17. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Ronco G, Rajkumar R, Qiao YL, Muñoz N and Franceschi S: Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomark Prev 15: 2148-2153, 2006.
18. Inglis S, Shaw A and Koenig S: Chapter 11: Hpv vaccines: commercial research & development. Vaccine 24: S99-S105, 2006.
19. Agarossi A, Ferrazzi E, Parazzini F, Perno CF and Ghisoni L: Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 81: 529-535, 2009.
20. Centurioni MG, Puppo A, Merlo DF, Pasciucco G, Cusimano ER, Sirito R and Gustavano CA: Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis 5: 77-83, 2005.
21. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaio F and Manca N: Detection and genotyping of human papillomavirus in cervical samples from italian patients. J Med Virol 75: 588-592, 2005.
22. Rassu M, Bertoloni G, Mengoli C, Peron A, Benedetti P and Palù G: HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy. Scand J Infect Dis 37: 476-481, 2005.
23. Ronco G, Ghisetti V, Segnan N, Snijders PJF, Gillio-Tos A, Meijer CJLM, Merletti F and Franceschi S: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41: 297-305, 2005.
24. Verteramo R, Pierangeli A, Calzolari E, Patella A, Recine N, Mancini E, Marcone V, Masciangelo R, Bucci M, Antonelli G and Degener AM: Direct sequencing of HPV DNA detected in gynaecologic outpatiens in Rome, Italy. Microbes Infect 8: 2517-2521, 2006.
25. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S and Perino A: Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, south Italy. Cancer Epidemiol Biomarkers Prev 17: 2002-2006, 2008.
26. Capra G, Giovannelli L, Bellavia C, Migliore MC, Caleca MP, Perino A and Ammatuna P: HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res 133: 195-200, 2008.
27. Del Prete R, Di Taranto AM, Lipsi MR, Nirchio V, Antonetti R and Miragliotta G: Prevalence and genotypes identification of human papillomavirus infection in a population of south Italy. J Clin Virol 42: 211-214, 2008.
28. Menzo S, Ciavattini A, Bagnarelli P, Marinelli K, Sisti S and Clementi M: Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. BMC Microbiol 8: 112-118, 2008,
29. Broccolo F, Chiari S, Piana A, Castiglia P, Dell'Anna T, Garcia-Parra R, Maneo A, Villa A, Leone EB, Perego P, Maida A, Mangioni C and Cocuzza CE: Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of north Italy. J Med Virol 81: 278-287, 2009.
30. Kay P, Meehan K and Williamson AL: The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 105: 159-170, 2002.
31. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS and Burk RD: PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310, 1997.
32. Giovannelli L, Lama A, Capra G, Giordano V, Aricò P and Ammatuna P: Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the Hybrid Capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 42: 3861-3864, 2004.
33. De Sanjosè S, Diaz M, Castellsaguè X, Clifford G, Bruni L, Muñoz N and Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Inf Dis 7: 453-459, 2007.
34. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM and Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265, 2002.
35. Van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ and van den Tweel J: Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156: 158-164, 2002.
36. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA and Dubin G: Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367: 1247-1255, 2006.
37. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmer? J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO and Dubin G for the HPV PATRICIA study group: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369: 2161-2170, 2007.
38. Jenkins D: A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol 110: S18-25, 2008.
39. Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU and Barr E: Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 107: 18-27, 2006.